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Background: The global resurgence of tuberculosis is a significant threat. Lamiaceae members have been used in
folk remedies for centuries. This study was designed to assess the in-vitro antimycobacterial activity of eighteen
crude extracts from six plants (Lamiaceae) and to characterize their phenolic and flavonoid compounds.
Methods: Six Turkish medicinal plants of the family Lamiaceae (Stachys tmolea Boiss., Stachys thirkei C. Koch, Ballota
acetabulosa (L.) Benth., Thymus sipthorpii Benth., Satureja aintabensis P.H. Davis, and Micromeria juliana (L.) Benth. ex
Reich.) were collected in 2009 – 2010. Dried and crushed plant samples were subjected to sequential extraction
with petroleum ether, ethyl acetate, and methanol in order of increasing polarity. A broth microdilution method
was employed to screen extracts against four mycobacterial strains of Mycobacterium tuberculosis. Phenolic and
flavonoid compounds were characterized by liquid chromatography–mass spectrometry.
Results: S. aintabensis, T. sibthorpii, and M. juliana were found to develop considerable activity against the four
strains of M. tuberculosis with the minimal inhibitory concentrations value of 12.5-100 μg/ml. S. aintabensis and
T. sibthorpii extracts killed M. tuberculosis with the minimum bactericidal concentration value of 50–800 μg/ml. On
the basis of these prominent antimycobacterial activity, we suggest that they could be a source of natural
anti-tuberculosis agents.
Conclusion: S. aintabensis and T. sibthorpii showed activity by killing Mycobacteria strains. The major phenolic
compound was rosmarinic for T. sibthorpii and S. aintabensis. Flavonoids might be “a modal” for the drug design.
Keywords: Mycobacterium tuberculosis, Antimycobacterial activity, Satureja aintabensis, Thymus sipthorpii,Lamiaceae,
Phenolic, FlavonoidBackground
Tuberculosis (TB) is an infectious bacterial disease caused
by Mycobacterium tuberculosis, which most commonly
affects the lungs. It is a well-known disease that has
afflicted humans since ancient times. Although tremen-
dous efforts have been made to control TB at global and
national levels, approximately one third of the world’s
population is infected with M. tuberculosis, eight million* Correspondence: etekwu@yahoo.fr
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stated.people develop tuberculosis disease annually, while two
million people die and another three million new cases
occur each year [1]. The global resurgence of TB and the
development of drug resistance, multidrug-resistant (MDR)
and extensively drug resistant (XDR) strains present signifi-
cant threats to TB control. The alarming increase of MDR-
TB cases requires the urgent development of new, more
effective and safer anti-tuberculosis (anti-TB) drugs.
Lamiaceae members have been used as tea, spice or in
folk remedies for centuries. The plant family Lamiaceae
has a global distribution, and comprises more than 7200
species across approximately 240 genera [2]. Turkey is
regarded as an important gene-center for the plant familytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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demic to Turkey, and the rate of endemism in the family
is 44.2% [3].
Stachys L. is one of the largest genera of the family
Lamiaceae, and is used in herbal remedies and is con-
sumed as a tea in Anatolia and Iran. Decoctions or infu-
sions of Stachys are applied as tonics to treat skin
complaints, or taken internally for stomach disorders [4].
The antibacterial [5], anticancer [6] and antioxidant effects
[7] of the genus are described in the literature. The genus
Thymus (Lamiaceae) has numerous species and varieties
and the ratio of endemism in the genus is 53% in Turkey
[3]. Thymus oil is widely used as an antiseptic agent in
many pharmaceutical preparations and as a flavoring agent
for many kinds of food products [8]. In Turkey the genus
Ballota is represented by eleven species and six subspecies,
of which ten which are endemic [9]. Ballota species have
been used in the treatment of wounds and burns, gastro-
intestinal disorders, as diuretics, in the treatment of hem-
orrhoids as infusions, as a choleretic and to prevent coughs
in Turkish folk medicine [10].
M. juliana has several medicinal uses, such as prevent-
ing diabetes, tonsillitis, dyspepsia, stomach ulcers, lower-
ing cholesterol, as an anti-spasmodic and preventing
bronchitis, common cold, dysmenorrhea, prostate prob-
lems and kidney stones [11].
Many members of the genus Satureja are well known
for their aromatic and medicinal character. They are
used as culinary herbs and in folk medicine to treat
various ailments, based on their different plant activ-
ities. The essential oil isolated from various Satureja
species possesses certain biological properties, such as
antifungal [12], antibacterial [13], anticholinesterase
and antioxidant [14], and anti-HIV-1 [15] properties.
Medicinal plants have long been used in traditional
healthcare systems to cure various ailments including
tuberculosis [16]. Natural plant products have provided
an alternative source for the development of antimicro-
bial drugs [17].
Flavonoids have been recognized as having several bio-
logical properties such as being anti-oxidant, anti-allergic
and anti-infectious. Some flavonoids show antiviral and
antibacterial activities such as quercetin, which is an
HIV1-protease inhibitor [18]. Myricetin is also shown to
inhibit the growth of vancomycin-resistant enterococci
[19].
Numerous examples of interesting secondary metabolites
with antimicrobial activity have been isolated from natural
sources, indicating that natural products could be a useful
field for the discovery of new anti-TB leads. The antimyco-
bacterial properties of medicinal plants are increasingly
being reported from different parts of the world, and anti-
mycobacterial activities of members of the Lamiaceae fam-
ily have been reported by some authors [20,21].In this study, six plants of the Lamiaceae family (Stachys
tmolea Boiss., Stachys thirkei C. Koch, Ballota acetabulosa
(L.) Benth., Thymus sipthorpii Benth., Satureja aintabensis
P.H. Davis and Micromeria juliana (L.) Benth. ex Reich.)
were investigated with traditional claims for several dis-
eases. The objective of the present study was to evaluate
the antimycobacterial activities and determine the phen-
olic composition of S. tmolea, S. thirkei, B. acetabulosa,
T. siptorpii, S. aintabensis, and M. juliana. To the best of
our knowledge, these six plants had not previously been
screened for their activity against M. tuberculosis.
Methods
Plant materials
Six Turkish medicinal plants of the family Lamiaceae
(S. tmolea, S. thirkei, B. acetabulosa, T. sibthorpii, S.
aintabensis and M. juliana) were selected for their
antimycobacterial activities. All the plant materials
were further identified in the Department of Biology,
University of Balikesir-Turkey, by Professor Gulendam
Tumen. Voucher specimens were deposited at the
Herbarium of Balikesir University, Department of Biology.
The details herbarium data about plants were given with
their locality, altitude, collection time, acquisition code
numbers are listed in Table 1.
Preparation of extracts
The dried aerial parts of each plant (six plants) were cut
into small pieces, weighed and subjected to a sequential ex-
traction with different solvents according to their increas-
ing polarity: petroleum ether, ethyl acetate, and methanol.
For each sample, the plant material and respective solvents
were left to macerate for two weeks at room temperature.
The extracts were filtered through Whatman’s No. 1 filter
paper. The residue was re-extracted successively with the
different solvents mentioned. Solvents were evaporated
under reduced pressure using a rotavapor (Heidolph).
Therefore, three fraction extracts of petroleum ether frac-
tion (PEF), ethyl acetate fraction (EAF) and methanol
fraction (MEF) were obtained for each herb. The total
extraction yield, expressed as a percentage, is given in
Table 2. Dry fractions were stored in a deepfreeze at −20°C
until use.
Liquid chromatography–mass spectrometry analysis
Chemicals and samples
Gradient grade MeOH and acetonitrile were purchased
from Merck. Gradient grade water (18 m) was prepared
by using a Purelab Option-Q elga dv25 system. All stand-
ard stock solutions (1 mg/ml) were prepared by dissolving
each compound in MeOH. Standards, rosmarinic acid,
trans-cinnamic acid, and ferulic acid were purchased from
Aldrich, caffeic acid and gallic acid from Sigma-Aldrich
and all other chemicals used were obtained from Sigma.
Table 1 Plant herbarium data according to locality, altitude, collection time, and herbarium number
Plant no Plant species Locality Altitude Collection time Herbarium number
1 Stachys tmolea Boiss. Balikesir, Edremit, Kazdagi National Park 1400 m 11 June 2010 FS1550
2 Stachys thirkei C. Koch. Sakarya, Akyazı, Davlumbaz plateau 1300 m 13 June 2010 FS1551
3 Ballota acetabulosa (L.) Benth Balikesir Gomec, Madra 300 m 3 June 2010 FS1552
4 Thymus sibthorpii Benth. Tekirdag 1500 m 20 June 2009 FS1553
5 Satureja aintabensis P.H. Davis Gaziantep, Duluk Forest 850 m 15 July 2009 FS1554
6 Micromeria juliana (L.) Benth. ex Reich Balikesir Edremit, Kazdagi 450 m 6 August 2009 FS1555
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(Sartorius, Ø 0.22 μm.) before injection into the capillary.
Liquid chromatography–mass spectrometry conditions
Analyses were performed with an Agilent Liquid chro-
matography–mass spectrometry (LC-MS) system (1200
LC with a single quadrupole) with Electrospray Ionisation
(ESI) source-negative mode. Source parameters were
optimized to provide highest sensitivity. The source pa-
rameters are: Gas temperature 350°C, drying gas flow 12
l/min, nebulizer pressure 50 psi, capillary voltage 3500 V.Table 2 Antimycobacterial activity (MIC and MBC, μg/ml) of t




Stachy stmolea PEF 0,59 >6400 >6400 nd
EAF 3,02 >6400 >6400 nd
MEF 6,52 >6400 >6400 nd
Stachys thirkei PEF 0,41 >6400 >6400 nd
EAF 4,87 >6400 >6400 nd
MEF 11,21 >6400 >6400 nd
Ballota acetabulosa PEF 0,73 200 400 800
EAF 2,30 >6400 >6400 nd
MEF 8,87 >6400 >6400 nd
Thymus sibthorpii PEF 0,61 12,5 50 800
EAF 3,18 12,5 12,5 400
MEF 3,85 800 200 1600
Satureja aintabensis PEF 0,58 25 50 100
EAF 3,24 12,5 12,5 50
MEF 6,39 100 400 3200
Micromeria juliana PEF 0,29 1600 1600 -
EAF 2,32 100 50 200
PEF 5,26 1600 1600 -
Standard drugs
SM 0.63 0.63 1.25
INH 0.16 0.31 0.31
RIF 0.78 0.39 0.78
EMB 2.73 2.73 2.73
Nd, not determined due to the fact that the samples were not active on H37Rv and
tested; PEF, Petroleum ether fraction; EAF, Ethyl acetate fraction; MEF, Methanol fracSeparation was carried by a Poroshell 120 SB-C18 column
(2.1 × 100mm 2.7um). Mobile phases are A: Water (10
mM Ammonium Acetate + 0.2% Formic Acid) and B
(100% Methanol). The gradient program is: Start with 10%
B and hold 0.2 min; then increased to 30% B until 3 min;
increase B to 80% until 20 min; increase B to 95% at 20.1
min and hold 2 min; decrease B to 10%. Total run time is
35 min. Injection volume is 5 μl. The detection was
accomplished using MS SIM mode. Scan mode is also
used. LC–MS analysis was based in the method described
by [22].he 18 plant extracts
tration (μg/ml) Minimum bactericidal concentration (μg/ml)
n 1 Strain 2 H37Rv H37Ra Strain 1 Strain 2
nd - - - -
nd - - - -
nd - - - -
nd - - - -
nd - - - -
nd - - - -
400 800 800 1600 1600
nd - - - -
nd - - - -
400 800 800 800 800
400 400 400 400 400
800 >6400 >6400 >6400 >6400
100 100 100 100 100
50 50 50 50 50
1600 >6400 >6400 >6400 >6400
nd* >6400 >6400 - -
400 >6400 >6400 >6400 >6400
- >6400 >6400 - -
0.63 - - - -
0.31 1.25 1.25 1.25 1.25
0.78 6.25 3.13 6.25 6.25
1.37 - - - -
H37Ra; nd*: not determined due to insufficient amount of the sample;(−) not
tion; SM, Streptomycin; INH, Isoniazid; RIF, Rifampicin; EMB, Ethambutol.
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For antimycobacterial activity, stock solutions of extracts
were prepared in advance at a concentration of 100 mg/
ml in dimethylsulphoxide (DMSO, Merck, Germany)
and sterilized by filtration through membrane filter (Ø
0.20 μm; Minisart, Sartorius Bitech, Germany). Stock
solutions were kept at −20°C until use. Before the bio-
assay, working solutions were prepared by diluting stock
solutions to four times (4×) the maximum desired final
testing concentration in sterile Middlebrook 7H9 broth.
The final concentration of DMSO in all assays was ≤2%,
and this was used as a solvent control. It has been shown
to be nontoxic for mycobacteria at this concentration.
Anti-tuberculosis drugs
Isoniazid (INH), rifampicin (RIF), streptomycin (SM),
and ethambutol (EMB) (Becton, Dickinson and company,
Spark, U.S.A) were used as standards. Stock solutions
were prepared in sterile distilled water according to the
manufacturer's recommendations.
Mycobacterium strains and growth conditions
Two well-characterized strains of M. tuberculosis were
obtained from the American Type Culture Collection
(ATCC): M. tuberculosis H37Rv (ATCC 27294) and H37Ra
(ATCC 25177), sensitive to all first-line anti-tuberculosis
drugs. Two clinical strains namely “strain1” and “strain2”
isolated from TB patients were also used. The organisms
were maintained on slant of Middlebrook 7H10 agar
(Difco, USA) supplemented with 0.5% glycerol and 10%
OADC (Oleic acid, Albumin, Dextrose, and Catalase;
Difco).
Preparation of inoculums for anti-tuberculosis assay
All strains were grown at 37°C in Middlebrook 7H9 Broth
(7H9) (Becton Dickinson), supplemented with 0.2% v/v gly-
cerol (Sigma Chemical Co., St. Louis, MO, USA), and 10%
v/v oleic acid, albumin, dextrose, and catalase (OADC; Bec-
ton Dickinson). PANTA 2.5% (Polymixin, Amphotericin B,
Naladixic acid, Trimethoprim and Azlocillin; Becton,
Dickinson), an antibiotic supplement, was also added to
prevent the growth of any non-mycobacteria.
A suspension was prepared in Middlebrook 7H9 Broth.
The turbidity of the suspension was adjusted to the
McFarland standard 1.0. The suspension was vortexed for
several minutes and allowed to precipitate larger particles
then to sit for 20 min. The supernatant was transferred to
an empty, sterile tube and allowed to sit for a further 15
min. After being transferred to a new sterile tube, the
suspension was adjusted to a 0.5 McFarland turbidity
standard by visual comparison. One ml of the adjusted
suspension was diluted in 4 ml of sterile saline.
To prepare inoculum from a positive BACTEC MGIT
tube, the positive tubes were used beginning from theday after it first became positive (day 1 positive) up to
and including the fifth day (day 5 positive). The positive
tubes older than five days were subcultured into fresh
growth-medium. The tubes which were day-1 and day-2
positive proceeded to the inoculation procedure for the
susceptibility test. The tubes between day 3 and day 5
positive were diluted using a 1 ml of the positive broth
with 4 ml of sterile saline, the total is 5, then this diluted
suspension were used for inoculation procedures. Inocula
prepared from a Day 1 to Day 5 positive MGIT 7 mL
tube range were between 0.8 × 105 to 3.2 × 105 CFU/mL.
Each assay was performed according to the MGIT man-
ual Fluorometric susceptibility test procedure recom-
mended by the manufacturer, Becton, Dickinson and
Company [23,24].
Antimycobacterial susceptibility assay
The activity of all extracts against the aforementioned M.
tuberculosis strains was tested using the Microplate
Presto Blue Assay (MPBA) following the procedure pre-
viously described Collins & Franzblau [25] and modified
by Jimenez-Arellanes et al. [26] using Presto blue reagent.
Prior to the bioassay, working solutions of the extracts
were prepared by diluting stock extract solutions to four
times the maximum desired final testing concentration in
sterile 7H9 broth.
The minimal inhibitory concentration (MIC)
Antimycobacterial susceptibility assay was done accord-
ing to National Committee for Clinical Laboratory Stan-
dards [24,27].
The test was performed in 96-well sterile microplates.
All wells received 100 μl of supplemented Middlebrook
7H9 broth. One hundred microliters of a 4× working so-
lution of 18 plant extracts were added to the first column
of each row. Using a multichannel pipette, 100 μl was
transferred from column 1 to column 2, and the contents
of the wells were mixed well. Identical serial 1:2 dilutions
were continued through column 10, and 100 μl of excess
medium was discarded from the wells in column 10.
Then, 100 μl of M. tuberculosis inoculum was added to
the wells in rows A to H in columns 1 to 11. Thus, the
wells in columns 11 and 12 served as drug-free controls.
Final test concentrations ranges were 6400–12.5 μg/ml in
the mixture.
Each microplate was incubated for 5 days at 37°C.
Following incubation, one control growth (well A11) was
developed with 20 μl of Presto blue solution (Invitrogen,
Life Technologies). The plates were re-incubated at 37°C
for 24 h. After this incubation, if the well remained blue,
the reagent would be added to another control well and
the result would be read on the following day. If the color
turned pink, all the wells in microplate received the
Presto blue solutions in the same way and were
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wells recorded. A blue color in the well was interpreted
as no growth, and wells with a well-defined pink color
were scored as positive for growth. The minimal inhibi-
tory concentration (MIC) was defined as the lowest
concentration of sample that prevents a color change
to pink. Streptomycin, isoniazid, ethambutol and rifam-
picin were included as standard drugs. Each experiment
was performed in triplicate at least twice.
The minimum bactericidal concentration (MBC)
In this study, bactericidal activity was determined by micro-
dilution methods as described in our recent publication
[28]. Briefly, standard broth dilution technique for MICs
was first performing as described above. Then, samples of
those dilutions with no visible growth were transferred to
new plate prepared with fresh supplemented Middlebrook
7H9 broth. Twenty microliters (20 μl) of mycobacterial
suspensions were transferred from the former to a new
microplate and this was incubated and developed with
Presto Blue as for MPBA. The MBC corresponded to the
minimum extract concentration that did not cause a
color shift in cultures re-incubated in fresh medium
[29,30].
Results and discussion
LC/MS characterization of the phenolic composition of
samples
Standard phenolic, flavonoids and samples were analyzed



































Figure 1 ESI-TIC-SIM chromatogram of standard phenolics (details acTheir chromatographic retention time were given in
Figure 1, Figure 2 and Table 3.The chemical concentra-
tions (μg/g) of phenolic and flavonoids of the tested
plants in PEF, EAF and MEF were given in Table 4.
In the evaluation of the phenolic and flavonoid compos-
ition of samples; for MEF extracts of T. sibthorpii; ros-
marinic acid, caffeic acid, apigenin 7 glikozide, quercetin,
and luteolin were major phenolic compounds in the sort
descending. On the other hand, we also determined gallic
acid; chlorogenic acid, syringic acid, p-coumaric acid; fer-
rulic acid, vitexin, naringin, rutin hidrat, oleuropein and
naringenin as minor level.
Epicatechin, hesperidine, and trans-cinnamic acid
were not detected. In the EAF extracts of T. sibthorpii,
rosmarinic acid, luteolin, caffeic acid, naringenin, and
quercetin were the major constituents in decreasing
concentrations respectively. Gallic acid, p-coumaric,acid
and apigenin 7 glycoside were found in less amount.
Some of the phenolic and flavonoids such as chloro-
genic acid, syringic acid, epicatechin, ferrulic acid,
vitexin, naringin, and rutin hidrat were not detected in
the EAF extracts of T. sibthorpii.
For S. aintabensis, while the major phenolic compounds
were rosmarinic acid, hesperidin, luteolin, caffeic acid, and
naringenin for MEF extract in descending order, gallic acid,
chlorogenic acid, syringic acid, vitexin, naringin, rutin
hidrat, apigenin 7 glycoside, and quercetin were exist in
the moderate to less amount. On the other hand, epicate-
chin, p-coumaric acid, ferrulic acid, and trans-cinnamic
acid were not detected.min20 25 30
cording to retention time are given in the Table 3).
Figure 2 ESI-TIC SIM chromatogram of A) T. sibthorpii EAF extract B) T. sibthorpii MEF extract C) S. aintabensis EAF extract D)
S. aintabensis MEF extract.
Table 3 LC-MS characteristics of phenolic compounds according to signal no (S.N.), retention times (R.T.) (min), and
molecular ions [M-H+](m/z) at fragment ion 80 eV
S.N. R.T. [M-H+] Phenolics Samples
1 1,6 169 Gallic acid 1B, 1C, 2B, 2C, 3B, 3C, 4B, 4C, 5B, 5C, 6B, 6C,
2 6,17 353 Chlorogenic acid 1A,1B, 1C, 2A, 2B, 2C, 3A, 4B, 5B, 5C, 6B, 6C
3 6,53 179 Caffeic acid 1B, 1C, 2B, 2C, 3B, 3C, 4B, 4C, 5B, 5C, 6B,6C
4 7,3 197 Syringic acid 4C, 2B, 2C, 4B, 5B, 5C, 6B, 6C
5 7,34 289 (−)-Epicatechin 3C
6 8,28 163 ρ-coumaric acid 1B, 1C, 2C, 3B, 3C, 4B, 4C, 5B, 6C
7 8,9 193 Ferrulic acid 1C, 2C, 4B, 5B, 6C
8 9,72 431 Vitexin 1C, 2B, 2C, 4B, 5B, 6B, 6C
9 10,6 359 Rosmarinic acid 2B, 2C, 3B, 3C, 4B, 4C, 5B, 5C, 6B, 6C
10 10,69 579 Naringin 1B, 1C, 2B, 2C, 3B, 4B, 5B, 5C, 6B, 6C
11 10,76 609 Rutin hidrat 1B, 1C, 2B, 3B, 3C, 4B, 5B, 6B, 6C
12 11,12 610 Hesperidine 1B, 5B, 5C, 6B, 6C
13 11,65 431 Apigenin 7glikozide 1B, 1C, 2B, 2C, 3B, 3C, 4B, 4C, 5B, 5C, 6B, 6C
14 11,96 539 Oleuropein 1C, 3C, 4B, 5B, 6B, 6C
15 12,57 147 trans-cinnamic acid
16 13,47 301 Quercetin 1C, 4B, 4C, 5B, 5C, 6B, 6C
17 13,613 271 (±)-Naringenin 1B, 1C, 2B, 2C, 3C, 4B, 4C, 5B, 5C, 6C
18 14,36 285 Luteolin 1B, 1C, 2B, 2C, 3B, 3C, 4B, 4C, 5B, 5C, 6B, 6C
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Table 4 Chemical concentrations (μg/g) of phenolic of the tested plants in petroleum ether (PEF), ethyl acetate (EAF) and methanol (MEF) extract fractions
Plant
No
Extracts Chemical concentrations of phenolic
1 2 3 4 5 6 7 8 9 10 11 12 13 14 1 16 17 18
Stm
PEF (A) * 35,88 * * * * * * * * * * * * * * * *
MEF (B) 193,86 19821,5 1235,31 * * 122,21 * * * 194,67 75,76 1690,35 5888,53 * * * 54,01 214,67
EAF (C) 504,15 371,03 3422,58 310,78 * 666,26 257,13 206,38 * 276,64 71,33 * 1986,35 195,20 * 68,44 285,56 1038,67
Sth
PEF (A) * 0,81 * * * * * * * * * * * * * * * *
MEF (B) 27,02 17965,90 2092,20 363,51 * * * 276,36 460,80 202,86 80,34 * 1851,75 * * * 66,17 233,10
EAF (C) 108,31 12192,68 5208,54 1205,07 * 200,43 257,56 263,55 1151,40 136,21 * * 1255,18 * * * 121,72 465,49
Ba
MEF(B) 18,45 6856,7 1567,83 * * 144,04 * * 12258,76 301,17 120,96 * 1104,05 * * * * 120,51
EAF (C) 63,11 189,34 519,04 * 330,09 160,78 * * 6885,16 * 1451,65 * 151,11 119,81 * * 30,54 55,11
Ts
MEF (B) 268,9 263,86 5032,83 340,2 * 235,97 251,6 85,24 81432,13 377,93 191,26 * 940,27 141,95 * 645,37 452,04 3632,13
EAF (C) 39,15 * 1908,9 * * 148,3 * * 6074,77 * * * 97,8 * * 666,37 1436,47 2390,07
Sa
MEF (B) 53,45 234,71 1383,2 443,75 * * * 106,01 42936,05 260,38 238,73 10117,43 389,33 551,37 * 249,27 1084,98 2446,5
EAF (C) 93,78 56,14 2587,51 956,49 * 230,23 177,14 * 26995,81 7748,81 * 5633 282,47 * * 1518,12 7729,86 5025,99
Mj
PEF (A) * * * * * * * * * * * * * * * * * *
MEF (B) 76,51 5256,91 1603,05 128,17 * * * 383,28 32457,86 581 5336,78 6013,16 480,88 201,9 * 684,28 * 242,2
EAF (C) 129,07 167,96 1434,85 215,8 * 92,85 170,23 550,55 4449,22 60,7 679,12 734,01 92,31 34,1 * 192,37 79,92 226,36
Stm: Stachys tmolea; Sth: Stachys thirkei Ba: Ballota acetabulosa Ts:Thymus sibthorpii Sa: Satureja aintabensis Mj:Micromeria juliana;EAF: EthylAcetat; MEF: Methanol; 1; Gallicacid 2; Chlorogenicacid 3; Caffeicacid 4;
Syringicacid 5; Epicatechin 6; P-coumaricacid 7; Ferrulicacid 8; Vitexin 9; Rosmarinicacid 10; Naringin 11; RutinHidrat 12; Hesperidine 13; Apigenin 7 Glikozide 14; Oleuropein 15; Trans-cinnamicacid 16; Quercetin 17;
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highest concentration. It is followed by naringin, narin-
genin, hesperidine, caffeic acid, and quercetin. The lesser
quantity of substances were gallic acid, chlorogenic acid,
syringic acid, p-coumaric acid, ferrulic acid, and apigenin
7 glycoside. Some of the phenolic and flavonoids such as
epicatechin, vitexin, rutin hidrat, oleuropein, and trans-
cinnamic acid were not found.
For others, the major phenolic compounds for M. juliana
were rosmarinic acid, chlorogenic acid, rutin hydrate
and caffeic acid in the MEF extract. The major phenolic
compound for EAF and MEF extracts of B. acetabulosa
was chlorogenic acid.
The major phenolic compounds for S. thirkei were
chlorogenic acid, caffeic acid, ferulic acid, and rosmarinic
acid for EAH extract; chlorogenic acid and caffeic acid
for MEF extract. For S. tmolea the major phenolic com-
pound for EAF was caffeic acid.
The determination of oleuropein in some extracts of
plants such as EAF of S tmolea and B. acetabulosa; MEF
of T. sibthorpii and S. aintabensis; and also EAF and MEF
of M. juliana was one of the interesting and amazing
results for us. Because oleuropein which may have a role
in different mechanisms such as antioxidant, signaling
mecanism or decreased rates of cancer, commonly pre-
sented as related with olive leaves which is high amounts
in olive leaves such as 60–90 mg/g of dry matter [31] but
only little in olive oil [32].
Antimycobacterial activity
In this study, LC-MS revealed large quantity of rosmarinic
acid in all EAF and MEF extracts that showed antimyco-
bacterial activity: T. sibthorpii, S. aintabensis, M. juliana.
Many studies have suggested that high level of rosmarinic
acid might be associated with antimycobacterial activity
[21]. Many biological activities have been described for
rosmarinic acid, of which the main ones are: astringent,
antioxidative, anti-inflammatory, antimutagen, antibacter-
ial and antiviral [33]. The latter activity is used in the ther-
apy of Herpes simplex infections, with extracts of Melissa
officinalis containing rosmarinic acid.
As many different methods are available to evaluate
anti-tuberculosis activity, no specific cut-off value has yet
been established for the anti-tuberculosis activity of plant
extracts. In previous studies, plants extracts were consid-
ered active against M. tuberculosis and other related
Mycobacterium strains if MIC was ≤100 μg/ml [34]; ≤125
μg/ml [35]; ≤200 μg/ml [26,36]; ≤500 μg/ml [37]; ≤1600
μg/ml [38]; and ≤2048 μg/ml [28]. Other studies consid-
ered other quantifiable inhibitions as indication of activity
[21,39]. In this study, we interpreted activity as inhibition
at any values of MIC ≤6400 μg/ml, the highest test con-
centration. Plant extracts that did not exhibit inhibition at
up to 6400 μg/ml were considered inactive. However,activity was classified as significant if MIC < 100 μg/ml,
moderate if 100 < MIC ≤ 625 μg/ml or weak if MIC > 625
μg/ml.
Eighteen crude extracts from 6 Turkish plant species
of the family Lamiaceae were obtained by successive ex-
traction with three solvents of varying polarity.
The result showed that methanol gave highest yield of
extract compared to petroleum ether and ethyl acetate
extraction; the yield from petroleum ether was very low
(Table 2).
M. tuberculosis H37Rv ATCC 27294 and M. tuberculosis
H37Ra ATCC 25177 variants were used as target organ-
isms in the preliminary assays; all plant extracts that ex-
hibited activity were further tested against two clinical
strains (strain 1 and strain 2). The results are shown in
Table 2.
Our rationale for using H37Rv (ATCC 27294) and
H37Ra (ATCC 25177) was that they have drug susceptibil-
ity profiles that are reasonably representative of the major-
ity of drug-susceptible clinical isolates [40]; In addition,
they are used around the world as a standard, and could
provide an opportunity to identify new compounds effect-
ive against strains of M. tuberculosis. These results showed
that 10 of 18 extracts obtained from three solvents tested,
exhibited anti-tuberculosis activity against all the tested
M. tuberculosis strains, with MICs in the range 12.5–1600
μg/ml and MBC 50–1600 μg/ml. Out of these, according
to the classification used [41]: The three fractions of
S. aintabensis exhibited significant activity. The PEF and
EAF of S. aintabensis exhibited the most potent activity
against all the tested mycobacteria, with MICs value of
12.5–100 μg/ml, while the activity of its MEF was signifi-
cant against M. tuberculosis H37Rv (MIC 100μg/ml, mod-
erate against H37Ra (MIC 400 μg/ml) and weak against
the two clinical strains. PEF and EAF of S. aintabensis not
only inhibited the growth of mycobacteria, but also
showed bactericidal effect, with MBC value of 50 and 100
μg/ml against all the tested organisms. It is known that
phenolics are effective antimicrobial agents against a wide
array of microorganisms [42]. The strong antimycobacter-
ial properties of S. aintabensis observed in the present
study could be due to the presence of phenolic compounds
such as rosmarinic acid, naringenin, hesperidin, luteo-
lin and caffeic acid. This is the first study of the anti-
tuberculosis activity and chemical composition of S.
aintabensis. Antimycobacterial activity of S. aintaben-
sis was not previously reported.
The two fractions of T. sibthorpii, PEF and EAF, exhib-
ited significant activity against H37Rv and H37Ra with
MICs value of 12.5–50 μg/ml; and moderate activity
against the two clinical strains (MIC 400 μg/ml). The
MEF of T. sibthorpii exhibited moderate activity against
H37Ra (MIC 200 μg/ml) and weak activity against the
three others strains (800 and 1600 μg/ml). The PEF and
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all the tested respectively Mycobacteria, with MBC values
of 400 and 800 μg/ml.
The good antimycobacterial properties of T. sibthorpii
could depend on the presence of phenolic compounds
such as rosmarinic acid and caffeic acid. T. sibthorpii
was previously screened for its antimicrobial activity,
and its ethanol extract was reported to show broad anti-
microbial activity spectrum. Recent studies have shown
that Thymus species have strong antibacterial, antifungal
[43], antiviral and expectorating [44], activities, but no
data on its antimycobacterial activity seem to have been
published previously.
The PEF of B. acetabulosa presented moderate activity
against H37Rv, H37Ra and clinical strain 1 (MIC 200–
400 μg/ml), and weak activity against clinical strain 2
(MIC 800 μg/ml). This extract was also bactericidal, with
MBC value of 800 μg/ml against H37Rv and H37Ra and
1600 μg/ml against the two clinical strains. The EAF and
MEF of B. acetabulosa did not show any activity against
the tested strain Plants of this genus have been tradition-
ally used to treat nausea, vomiting, nervous dyspepsia,
and also are used for their antiemetic, sedative, antibac-
terial and mild astringent properties [45]. Aerial parts of
the plant are used internally to treat inflammation, to
suppress cough and against gastrointestinal disorders [46].
The antibacterial and antifungal activities of B. acetabu-
losa were reported by Dulger and Sener [46]. The antioxi-
dant activity of B. acetabulosa has been reported [10], but
to the best of our knowledge, the antimycobacterial prop-
erties have not been reported previously.
The EAF of M. juliana showed a most potent activity
with the minimal inhibitory concentration (MIC) value of
100 and 50 μg/ml, while the corresponding PEF and MEF
exhibited very weak activity (MIC 1600 μg/ml each). M.
Juliana extracts have no bactericidal effect. The antimy-
cobacterial activity exhibited by M. juliana probably de-
pends on the quantity of phenolics such as rosmarinic
acid, chlorogenic acid, rutin hydrate and caffeic acid.
It is also noticeable that all plant extracts containing high
levels of chlorogenic acid were inactive or showed very
weak activity against the strain of M. tuberculosis. This is
the case for MEF of M. juliana, MEF of B. acetabulosa,
MEF and EAF of S. thirkei, and EAF of S. tmolea.
The large amount of chlorogenic acid could react as an
antagonist to inhibit the activity of other compounds like
rosmarinic acid. When the composition of T. sibthorpii
and S. aintabensis extracts are compared to M. Juliana
extract, the three plants contain a large amount of ros-
marinic acid, however, T. sibthorpii and S. aintabensis
contain very low levels of chlorogenic acid, whereas M.
juliana is very rich in chlorogenic acid.
The two Stachys species (S. tmolea and S. thirkei)
showed no activity against the screened strains in ourassays. Essential oil from S. tmolea was investigated by
disk diffusion method on C. albicans by Goren et al.
(2011) [47] and was reported to show antifungal activity.
To the best of our knowledge, the above-mentioned anti-
fungal activity was the only previous reported activity on
S. tmolea. Regarding S. thirkei, no activity has been evalu-
ated until now.
The finding that the major phenolic compound of
S. tmolea and S. thirkei is chlorogenic acid could par-
tially explain their inactivity against M. tuberculosis.
In this study, we reported that PEF and EAF were
most active compared to the methanol fraction. This
might be because the mycobacteria, having a very lipid-
rich hydrophobic cell-wall, are often more susceptible to
compounds with weaker polarity [48].
Conclusion
Tuberculosis is a very serious disease in the world. A total
of 1.4 million people died from TB in 2011. One third of
the world’s population, especially from low- and middle-
income countries, is infected with Mycobacterium tubercu-
losis. In addition, approximately one in four deaths among
people with HIV is due to TB. MDR-TB, affecting 630,000
people in the world, is caused by inappropriate use of TB-
drugs, does not respond to standard treatments because it
is costly and ineffective to treat [49].
In the present investigation, we also demonstrated for
the first time the efficacy of the PEF and EAF of two
plant species, S. aintabensis and T. sibthorpii. In addition,
PEF extract of Ballota acetabulosa was also efficient
against M. tuberculosis strains including isolates taken
from patients. These extracts displayed very high activity,
not only by inhibiting but also by killing all of the Myco-
bacteria strains. The phenolics and flavonoids might rep-
resent promising sources of anti-TB drugs. The LC-MS
spectra of all the extracts revealed their main phenolic
composition, which was closely associated with the ob-
served antimycobacterial activity [50]. However, advanced
research will be necessary to confirm this hypothesis.
Consequently, compounds in the extracts and potential
activity may guide the future isolation and antimycobac-
terial evaluation of the active principles. Further phyto-
chemical and pharmacological studies of these plants are
clearly worthwhile. Flavonoids might be “a modal” for the
drug design. Identification of the antimycobacterial mech-
anism of action might be the key to the development of
these compounds.
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